samedan logo
 
 
spacer
home > ict > summer 2018 > navigating global complexities
PUBLICATIONS
International Clinical Trials

Navigating Global Complexities

Insurance is a small part of the global clinical trial process, but it can have a huge impact on the contract or clinical research company’s efforts geared towards ensuring trials proceed smoothly.

Making sure a clinical trial’s insurance policy stands up to the scrutiny of the ethics committee in each territory is essential. Inappropriate insurance documentation presented to the ethics committee meeting could delay the onset of the trial until at least their next meeting, reducing the patent exclusivity period, potentially costing millions of pounds and negatively affecting important business relationships.

Having a sound understanding of the legislation and regulations governing clinical trials in the territory where the company is testing is the best starting point.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kathryn Moon is ACII qualified and has worked in the insurance industry for over 20 years in a variety of roles including Account Broker, Project Manager, Development Manager, and Account Executive. She is currently Managing Director of the Coventry office of Gallagher – the global insurance broker, risk management services, and consulting firm – and an integral part of its UK life sciences specialism. Gallagher are also members of OBN.
spacer
Kathryn Moon
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics

IRBM, a global contract research organization (CRO), has strengthened its position in neurodegenerative disease research following an extension of its long-standing collaboration with CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington’s disease (HD).
More info >>

White Papers
 
Industry Events

ASGCT 22nd Annual Meeting

29 April - 2 May 2019, Washington Hilton, Washington, D.C

The 2019 ASGCT Annual Meeting is expected to be the largest in Society history, eclipsing the mark set by the 2018 meeting just last year. Join more than 3,500 researchers, clinicians, advocates, and industry leaders in discovering the latest science and technology surrounding gene and cell therapy.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement